Specific diabetes medications identified for concomitant osteoporosis Anjali Nimesh Nimesh9 July 2017 9:22 AM ISTType 2 diabetes (T2D) and osteoporosis often coexist in patients, but managing both conditions can be a challenge. A comprehensive review published in...
Canagliflozin lowers risk for heart failure in patients of DM : BMJ Dr. Kamal Kant Kohli Kohli17 March 2018 8:30 PM ISTDr.Elisabetta Patorno and associates conducted a Population-based retrospective cohort study to evaluate the cardiovascular safety of canagliflozin, a...
SGLT-2 inhibitors best for lowering mortality risk in T2DM : JAMA Dr. Kamal Kant Kohli Kohli22 April 2018 8:00 PM ISTThe comparative clinical efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl...
SGLT2 inhibitors may cause Fournier's gangrene of genital area in diabetics : FDA warns Hina Zahid31 Aug 2018 8:35 PM ISTThe Food and Drug Administration (FDA) has issued a warning regarding serious genital infection known as Fournier's gangrene that has been reported in...
Diabetes medications linked to increased risk of amputation Medha Baranwal Baranwal19 Nov 2018 7:28 PM ISTType 2 diabetes (T2D) patients treated with sodium-glucose cotransporter 2 (SGLT2) inhibitors have an increased risk of lower-limb amputation and...
Canagliflozin use not linked to increased fracture risk in diabetes Hina Zahid2 Jan 2019 7:28 PM ISTIn a Population-based new-user cohort study researchers have found that Canagliflozin use is not linked to increased risk for fracture. The study has...
Canagliflozin not only lowers blood sugar but also reduces kidney failure risk in Diabetes Dr. Kartikeya14 April 2019 8:28 PM ISTIn Phase 3 CREDENCE study, researchers found that in patients of Diabetes, along with controlling blood sugar Canagliflozin reduced the risk of kidney...
SGLT2 inhibitors and Atrasentan- New options to slow CKD progression in Diabetes Dr. Kartikeya2 May 2019 7:02 PM ISTSodium-glucose transport inhibitors (SGLT2 inhibitors) and Atrasentan are two new and emerging treatment options to slow Chronic kidney disease (CKD)...
Hydroxychloroquine as good as SGLT-2 inhibitors as add on therapy to lower blood sugar Deepanjana Sarkar1 May 2019 8:28 PM ISTHydroxychloroquine is as good as SGLT-2 inhibitors (sodium-glucose transport inhibitors)as an add on treatment for lowering blood sugar and HbA1c in...
CREDENCE Trial Unfolds the Potential of SGLT2 inhibitor Canagliflozin for Indian Type 2 Diabetes Mellitus patients Dr. Kartikeya12 Jun 2019 7:17 PM ISTSGLT2 Inhibitor Canagliflozin becomes the first therapy in 15 years that has been demonstrated to slow down the progression of CKD in patients with...
ADA 2019 Highlights: Primary And secondary Prevention Outcomes From CREDENCE Dr. Kartikeya16 Jun 2019 7:02 PM ISTThe CREDENCE Trial outcomes came as a big win for patients with Type 2 Diabetes Mellitus(T2DM) and Chronic Kidney Disease (CKD), considering the high...
Warning-SGLT2 Inhibitors may mask ketoacidosis preoperatively, prove fatal Hina Zahid22 July 2019 10:20 AM ISTSGLT2 Inhibitors may mask a lethal complication of diabetes namely ketoacidosis at the time of surgery and prove fatal, finds a new study.SGLT2...
